Veterinary Medicines

Nobilis IB+ND+EDS vakcina A.U.V.

Authorised
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Egg drop syndrome '76 virus, strain BC14, Inactivated
Download as PDF

Product identification

Medicine name:
Nobilis IB+ND+EDS vakcina A.U.V.
Active substance:
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Egg drop syndrome '76 virus, strain BC14, Inactivated
Target species:
  • Chicken (hen)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Newcastle disease virus, strain Clone 30, Inactivated
    4.00
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    unit(s)/dose
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    6.00
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    unit(s)/dose
  • Egg drop syndrome '76 virus, strain BC14, Inactivated
    6.50
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (hen)
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Chicken (hen)
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA13
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."